Exchange: NYSE·Updated 04:54 AM EDT

SYK News

News
all
press releases
ISRG Ahead of Q3 Earnings: Can Procedure Growth Sustain Momentum?
Intuitive Surgical's Q3 earnings hinge on robotic surgery growth, system demand and margins amid slowing US procedures, China headwinds and premium valuation.
Zacks
ISRG Ahead of Q3 Earnings: Can Procedure Growth Sustain Momentum?
Intuitive Surgical's Q3 earnings hinge on robotic surgery growth, system demand and margins amid slowing US procedures, China headwinds and premium valuation.
Zacks
More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYKPR NewswireNEW YORK, Oct. 15, 2026NEW YORK, Oct. 15, 2026 /PRNewswire/ --Pomerantz LLP is...
PR Newswire
ISRG Gains Nearly 12% in a Month: Should You Buy, Hold or Sell?
Intuitive Surgical shares have surged nearly 12% in a month ahead of Q3 earnings. Strong da Vinci 5 adoption and Ion growth fuel momentum, but valuation and risks linger.
Zacks
Why Did J&J Stock Fall After Q3 Earnings Despite Raised Guidance?
J&J's shares fell 5.8% despite an earnings beat and raised guidance, as MedTech weakness, drug sales shortfalls and acquisition costs weighed on results.
Zacks
Stryker launches Sonopet 3, delivering greater power and precision in ultrasonic tissue removal
Stryker launches Sonopet 3, delivering greater power and precision in ultrasonic tissue removal Stryker launches Sonopet 3, delivering greater power and precision in ultrasonic tissue removalPR NewswirePORTAGE, Mich., Oct. 14, 2026Stryker has received FDA 510(k) clearance for Sonopet 3 , the latest...
PR Newswire
Stryker To Invest In CMR Surgical; To Serve As U.S. Sales Agent For Versius Portfolio
(RTTNews) - Stryker (SYK) and CMR Surgical, a global robotics company, announced a strategic equity investment of approximately $400 million by Stryker with an exclusive option for Stryker to acquire the remaining equity of CMR Surgical, and an exclusive U.S. commercial agency ag...
Nasdaq News: Markets
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYKPR NewswireNEW YORK, Oct. 8, 2026NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Pomerantz LLP is...
PR Newswire
Tilray Brands, Inc. (TLRY) Reports Q1 Loss, Misses Revenue Estimates
Tilray Brands (TLRY) delivered earnings and revenue surprises of -68.42% and -1.98%, respectively, for the quarter ended August 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Stryker Stock In Focus As Truist Says CEO Transition Is Low-Risk, Cuts Price Target To $310
Stryker is preparing for a leadership transition as longtime CEO Kevin Lobo becomes Executive Chair, and Spencer Stiles takes over as CEO in January 2027.
Stocktwits
Can J&J's MedTech Business Rebound in Q3 After Q2 Slowdown?
J&J's MedTech faces Abiomed and competitive pressures, but Vision, Orthopedics and Surgery could drive a stronger second half.
Zacks

Advertisement|Remove ads.